Datar Announces $250M Contract for Cancer Detection Liquid Biopsies
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | May 10, 2022 | Cancer, Company News |
Datar announced a contract with Artemis DNA, which provides Next Generation Sequencing genetic testing and diagnostic laboratory services.
Read MorePosted by Andy Lundin | May 3, 2022 | Diagnostic Technologies |
Researchers have developed a new microfluidic microchip for diagnosing diseases that can be powered wirelessly by a smartphone.
Read MorePosted by Chris Wolski | Apr 29, 2022 | Prostate |
The incidence of more aggressive prostate cancer cases that are higher-grade disease and metastasis at diagnosis have risen.
Read MorePosted by Andy Lundin | Apr 12, 2022 | Prostate |
PSA screening for prostate cancer could be improved by accounting for genetic factors that cause PSA changes not associated with cancer.
Read MorePosted by Andy Lundin | Apr 8, 2022 | Cancer |
Research has provided more clues on the origins and progression of certain blood cancers, suggesting new ways to diagnose and treat leukemias.
Read More